A new study combines cfDNA fragmentomes and protein biomarkers to vastly improve early detection of ovarian cancer, offering a cost-effective and robust tool for mass screening. Study: Early detection ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results